Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 9/20 | 0.50 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 2/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21408418 | 0.88 | TBXAS1 (0.58) | TBXAS1EGLN3KDM4ETP53TSHR | |
| SCHEMBL21408577 | 0.88 | TBXAS1 (0.58) | TBXAS1EGLN3KDM4ETP53TSHR | |
| SCHEMBL9046908 | 0.81 | TBXAS1 (0.50) | TBXAS1EGLN3KDM4ETP53TSHR | |
| SCHEMBL23120204 | 0.79 | TBXAS1 (0.50) | TBXAS1EGLN3KDM4ETP53TSHR | |
| SCHEMBL11788 | 0.79 | — | — | |
| SCHEMBL8600458 | 0.78 | TBXAS1 (0.52) | TBXAS1EGLN3KDM4ETP53TSHR | |
| SCHEMBL1709955 | 0.78 | TBXAS1 (0.53) | TBXAS1EGLN3KDM4ETP53TSHR | |
| SCHEMBL21408486 | 0.78 | TBXAS1 (0.47) | TBXAS1EGLN3KDM4ETP53TSHR | |
| SCHEMBL21408488 | 0.78 | TBXAS1 (0.47) | TBXAS1EGLN3KDM4ETP53TSHR | |
| Hydrochloric Acid SCHEMBL6437681 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112794822-B | Cationic N-substituted aniline ionic liquid, polyionic liquid thereof, preparation method and application | 北京师范大学（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-112794822-B | Cationic N-substituted aniline ionic liquid, polyionic liquid thereof, preparation method and application | 北京师范大学（CN） | 2023-01-13 | — | — | CN | disclosed |
| CN-112794822-A | Cationic N-substituted aniline ionic liquid, polyionic liquid thereof, preparation method and application | 北京师范大学 | 2021-05-14 | — | — | CN | disclosed |
| US-20160264692-A1 | POLYMERS AND MEMBRANES FOR SEPARATION OF POLAR ORGANIC COMPOUNDS FROM AQUEOUS MIXTURES AND METHODS OF USING | UNITED STATES DEPARTMENT OF ENERGY | 2016-09-15 | — | — | US | disclosed |
| US-20160264692-A1 | POLYMERS AND MEMBRANES FOR SEPARATION OF POLAR ORGANIC COMPOUNDS FROM AQUEOUS MIXTURES AND METHODS OF USING | UNITED STATES DEPARTMENT OF ENERGY | 2016-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160264692-A1 | POLYMERS AND MEMBRANES FOR SEPARATION OF POLAR ORGANIC COMPOUNDS FROM AQUEOUS MIXTURES AND METHODS OF USING | PHOSPHO1, PEF1, PORCN | TBXAS1 2683/4885EGLN3 3950/4885KDM4E 4477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.